Peter Buser
Overview
Explore the profile of Peter Buser including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
51
Citations
1609
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Burkard T, Trendelenburg M, Daikeler T, Hess C, Bremerich J, Haaf P, et al.
PLoS One
. 2018 Oct;
13(10):e0202105.
PMID: 30273933
Background: In systemic lupus erythematosus (SLE), cardiac manifestations, e.g. coronary artery disease (CAD) and myocarditis are leading causes of morbidity and mortality. The prevalence of subclinical heart disease in SLE...
2.
Kaiser C, Galatius S, Jeger R, Gilgen N, Skov Jensen J, Naber C, et al.
Circulation
. 2014 Nov;
131(1):74-81.
PMID: 25411159
Background: Biodegradable-polymer drug-eluting stents (BP-DES) were developed to be as effective as second-generation durable-polymer drug-eluting stents (DP-DES) and as safe >1 year as bare-metal stents (BMS). Thus, very late stent...
3.
Reuthebuch O, Inderbitzin D, Ruter F, Jeger R, Kaiser C, Buser P, et al.
Innovations (Phila)
. 2014 Sep;
9(5):368-74.
PMID: 25251551
Objective: We present the post-CE(Conformité Européenne)-mark single-center implantation experience and short-term outcome with the second-generation transapical JenaValve transcatheter aortic valve implantation system. Methods: Patients [N = 27; 9 women; mean...
4.
Prognostic value of microvascular obstruction and infarct size, as measured by CMR in STEMI patients
van Kranenburg M, Magro M, Thiele H, de Waha S, Eitel I, Cochet A, et al.
JACC Cardiovasc Imaging
. 2014 Sep;
7(9):930-9.
PMID: 25212799
The aim of this study was to evaluate the value of microvascular obstruction (MO) and infarct size as a percentage of left ventricular mass (IS%LV), as measured by contrast-enhanced cardiac...
5.
Zellweger M, Fahrni G, Ritter M, Jeger R, Wild D, Buser P, et al.
JACC Cardiovasc Interv
. 2014 May;
7(6):615-21.
PMID: 24835324
Objective: This study sought to evaluate the prognostic value of routine stress myocardial perfusion scintigraphy (MPS) 5 years after percutaneous coronary intervention (PCI). Background: Current appropriate use criteria define routine...
6.
Bally K, Buechel R, Buser P, Tschudia P, Martinaa B, Zeller A
Swiss Med Wkly
. 2013 Nov;
143:w13896.
PMID: 24193548
Background: Despite the significant benefits of secondary prevention (SP) medication after acute myocardial infarction (MI), evidence suggests that these medications are neither consistently prescribed nor appropriately adhered to by patients....
7.
Brignole M, Auricchio A, Baron-Esquivias G, Bordachar P, Boriani G, Breithardt O, et al.
Eur Heart J
. 2013 Jun;
34(29):2281-329.
PMID: 23801822
No abstract available.
8.
Surder D, Pedrazzini G, Gaemperli O, Biaggi P, Felix C, Rufibach K, et al.
Heart
. 2013 Jan;
99(14):1034-40.
PMID: 23343688
Background: Percutaneous mitral valve repair (MVR) using the MitraClip system has become a valid alternative for patients with severe mitral regurgitation (MR) and high operative risk. Objective: To identify clinical...
9.
Kasper J, Bolliger D, Skarvan K, Buser P, Filipovic M, Seeberger M
Anesthesiology
. 2012 Aug;
117(4):726-34.
PMID: 22902962
Background: Right heart failure is an important cause of perioperative morbidity and mortality, and transesophageal echocardiography (TEE) is crucial for its diagnosis. However, only four of the 20 cross-sectional views...
10.
Studer M, Zuber M, Jamshidi P, Buser P, Erne P
Indian Heart J
. 2012 Jun;
63(3):289-90.
PMID: 22734356
A 61-year-old woman with a congenital double-chamber left ventricle (DCLV) was admitted because of an anterior ST-elevation myocardial infarction (STEMI). Urgent coronary angiography showed a thrombotic occlusion of the distal...